Skip to main content
APLM
NASDAQ Life Sciences

Apollomics H1 2026: Going-Concern Warning With Only $1.0M Cash

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$19
Mkt Cap
$55.384M
52W Low
$10.006
52W High
$31
52W Position info
90% above low
Off High info
39% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

APLM sits 90% above its 52-week low of $10.006.

Summary

Apollomics disclosed H1 2026 results with a going-concern warning: $1.0 million of cash at June 30, 2026, an $8.8 million half-year loss, and a terminated LaunXP license that erased revenue. The August 2026 private placement is not reflected in that cash balance.


Key Events · Earnings and Guidance · APLM

  • Going-Concern Warning Disclosed

    Management states substantial doubt exists about the Company's ability to continue as a going concern, with $1.0 million of cash at June 30, 2026 and net current liabilities of $9.6 million.

  • LaunXP Deal Terminated, Revenue to Zero

    The LaunXP license was terminated effective June 11, 2026 after LaunXP failed to remit $3.8 million; the $2.3 million receivable was fully impaired, leaving H1 2026 revenue at nil versus $8.5 million a year earlier.

  • Half-Year Loss Narrows to $8.8M

    Net loss was $8.8 million versus $12.5 million in H1 2025, helped by R&D falling 57% to $2.0 million and administrative expenses falling 69% to $4.5 million.

  • August Placement Not in Cash Balance

    The private placement closed August 14, 2026 — $8.0 million cash for 533,334 shares at $15.00 plus conversion of the $2.0 million CEO note into 166,667 shares at $12.00 — so it is excluded from the June 30, 2026 cash figure.


Analysis · APLM · Life Sciences

Apollomics' first-half 2026 interim statements carry an explicit going-concern qualification: management states that substantial doubt exists about the Company's ability to continue as a going concern, with $1.0 million of cash at June 30, 2026 against net current liabilities of $9.6 million. The company also lost its only revenue stream — the LaunXP license was terminated effective June 11, 2026 after LaunXP failed to remit $3.8 million, and the $2.3 million receivable was fully written off. Cost cuts are real (R&D down 57%, administrative down 69%), but the loss of $8.8 million in the half still outruns the cash balance. The August 2026 private placement ($8.0 million cash plus conversion of the CEO's $2.0 million note) closed after the balance sheet date and is not in the June 30 cash figure — that capital is what keeps the lights on near term, and further raises remain the stated plan.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51.2% of the 201 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, APLM was trading at $19.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $55.4M. The 52-week trading range was $10.01 to $31.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

APLM - Latest Insights

APLM
Aug 17, 2026, 7:23 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $23.55
Real-time Price: $19.00 info
Change: -$4.55 (-19%) info
Market Cap: $55.384M info
APLM
Aug 17, 2026, 4:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $23.55
Real-time Price: $19.00 info
Change: -$4.55 (-19%) info
Market Cap: $55.384M info
APLM
Aug 11, 2026, 4:35 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.16
Real-time Price: $19.00 info
Change: +$0.840 (+5%) info
Market Cap: $55.384M info
APLM
Jul 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $18.95
Real-time Price: $19.00 info
Change: +$0.050 (+0.26%) info
Market Cap: $55.384M info
APLM
Jun 24, 2026, 6:28 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $20.50
Real-time Price: $19.00 info
Change: -$1.50 (-7%) info
Market Cap: $55.384M info